Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Reported Sunday, Benitec Biopharma Announces Upcoming Phase 1b/2a BB-301 Clinical Study Update For Oculopharyngeal Muscular Dystrophy Patients In November 3, 2025 Webcast

Author: Benzinga Newsdesk | November 03, 2025 02:45am

Posted In: BNTC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist